Satralizumab shortage status
1 active shortage notice across 1 country.
Last updated 30 Oct 2026 · sourced from official medicines regulators
- Generic name (INN)
- Satralizumab
- Brand names
- Enspryng
- Class
- Auto-created by Health Canada backfill
Where Satralizumab is in shortage
Why Satralizumab is in shortage
- causes not stated by the regulator
Recent shortage history
- Colombia: resolved 29 Sept 2026 (began 10 Jul 2026)
- Canada: resolved (began 15 May 2024)
Frequently asked questions
Is Satralizumab currently in shortage?
Yes. As of the latest regulator updates, Satralizumab has 1 active shortage notice across 1 country (Colombia). Status is refreshed daily from official regulatory sources.
Why is Satralizumab in shortage?
Regulators attribute the current Satralizumab shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Satralizumab shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Satralizumab status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.